Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
Company leadership is framing the move as transformational.
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
The study targets patients with refractory, unresectable microsatellite-stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC)
The agreement will combine Biocytogen’s cutting-edge fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive drug development
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
Subscribe To Our Newsletter & Stay Updated
